Voya Financial Advisors’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Voya Financial Advisors’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-5,619	Closed	-$334K	–	516
2017 Q1	$334K	Sell	5,619 -49,381	-90%	-$2.89M	0.03%	364
2016 Q4	$3.07M	Buy	55,000 +2,552	+5%	+$147K	0.27%	75
2016 Q3	$3.21M	Sell	52,448 -864	-2%	-$56.6K	0.33%	61
2016 Q2	$3.36M	Buy	53,312 +809	+2%	+$50.9K	0.39%	49
2016 Q1	$3.15M	Buy	52,503 +210	+0.4%	+$12.8K	0.44%	46
2015 Q4	$3.7M	Buy	52,293 +3,968	+8%	+$281K	0.55%	40
2015 Q3	$3.1M	Sell	48,325 -5,595	-10%	-$435K	0.55%	35
2015 Q2	$4.18M	Buy	53,920 +2,309	+4%	+$180K	0.74%	32
2015 Q1	$4M	Buy	+51,611	New	+$3.79M	0.78%	33

Other funds holding PJP

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Atria Investments Charlotte, North Carolina $9.98B AUM 26.5% 1-Year Est. Return

Voya Financial Advisors's PJP Position: Q2 2017 in Review

Voya Financial Advisors sold out of Invesco Pharmaceuticals ETF (PJP) in Q2 2017, closing a stake of 5,619 shares — an estimated $334K sold.

Voya Financial Advisors first reported a position in PJP in Q1 2015 and held it in 9 quarters. The position peaked at $4.18M in Q2 2015. 99 funds tracked by Wall St. Rank hold PJP as of Q2 2017.

Voya Financial Advisors reported no remaining Invesco Pharmaceuticals ETF position as of Q2 2017 after selling out during the quarter.
Voya Financial Advisors sold 5,619 Invesco Pharmaceuticals ETF shares in Q2 2017, an estimated $334K.
Voya Financial Advisors first reported a position in Invesco Pharmaceuticals ETF in Q1 2015 and held it in 9 quarters.
Voya Financial Advisors's Invesco Pharmaceuticals ETF position peaked at $4.18M in Q2 2015.
99 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2017.

Based on Voya Financial Advisors's 13F filing for Q2 2017, filed 14 Aug 2017.